Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
Clinical trial NCT06904183 · RECRUITING
Trial details
- NCT number
- NCT06904183
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2029-03-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.